MAbSilico

MAbSilico is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2

Countries 1

Type of company: Small business

Antibody Humanization Increase an antibody's similarity to a variant produced naturally in humans.
Epitope Mapping Map the antibody-antigen binding region to define protein-protein interaction sites.
In Silico Humanization Predict epitope binding specificity, increase in vivo half-life and allow rapid modeling and humanization of antibodies.
SARS-CoV-2 (COVID-19) Antibodies Search for available SARS-COV-2 antibodies

In Silico Protein Sequence Analysis Use software to predict protein structural and functional features and secondary structure components.

In Silico Lead Optimization Use in silico design to enhance the ADME-PK properties of candidate drugs to maximize efficacy and safety.
Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

Target Identification Identify the target(s) of a biologically active substance.

Molecular Dynamics Software Run simulations that determine time-dependent behaviors of molecular systems.

Work with MAbSilico on Scientist.com

For prices, more details, or to contact MAbSilico, visit Scientist.com.